Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution.
Scientists have engineered bacteria to produce designer proteins by smuggling artificial amino acids, enabling precise drug delivery and multifunctional applications.
Christine Dunham is a leading expert on the ribosome—an elaborate macro-molecular machine that operates like a factory within a cell to manufacture proteins. "The ribosome is really the most ...
Scientists have identified a critical breakdown in the cellular machinery that produces proteins in aging brains.
A recent study by Fred Hutch biochemist Christopher Lapointe, PhD, and his colleagues, uses innovative lab techniques to ...
When Associate Professor Eliezer Calo PhD '11 was applying for faculty positions, he was drawn to MIT not only because it's ...
The origin of the nucleus remains hotly debated among scientists, but new imaging and genomic data are shedding light on this billion-year-old mystery.
A pink ribosome surrounds part of a red-and-yellow helix-shaped strand of messenger RNA while a yellow protein branch extends from the ribosome. A graphic representation of a ribosome (pink) ...
Ribosomes—the tiny factories that build proteins in our cells—don't all work with the same efficiency. Researchers from Japan have discovered that ribosomes actually compete with one another, and ...
Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy with significant clinical challenges due to its heterogeneity and high relapse rate. Dysregulated ribosome biogenesis is a ...
When we think about the blueprint of life, we tend to focus on DNA—the genetic code stored in every cell of our bodies. But DNA is only part of the story. For those instructions to matter, they must ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results